市場調查報告書
商品編碼
1439262
心電圖 (ECG) 監測設備 - 全球市場考量、競爭格局、市場預測 (2030)ECG Monitoring Equipment - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
2021年全球心電圖(ECG)監測設備市場規模估計為44.4億美元,預計到2030年將達到62億美元,2024-2030年預測期間複合年增長率為5.74%。對心電圖 (ECG) 監測設備的需求主要是由心血管疾病患病率上升、產品開發技術進步、老年人口和久坐生活方式的增加以及對心血管疾病的認識不斷提高所推動的。
心電圖(ECG)監測設備市場動態
心電圖(ECG)監測設備是心率感知、診斷心肌缺血和梗塞、傳導系統缺陷、前驅、長QT症候群、心房異常、心包膜炎和心室肥厚等最重要的測試,結果證明是非常有益的。
根據世界衛生組織 (WHO) (2021) 發布的數據,心血管疾病 (CVD) 是全球死亡的主要原因,該類疾病每年估計奪走 1,790 萬人的生命。
CVD 被歸類為一組專門影響心臟和血管的疾病。CVD包括冠狀動脈心臟病、風濕性心臟病、腦血管疾病。
此外,世界衛生組織 (2021) 的相同數據指出,超過五分之四的 CVD 死亡主要是由中風和心臟病發作引起的,其中三分之一的死亡發生在 70 歲之前。超過四分之三的心血管疾病死亡發生在低收入和中等收入國家。
根據European Society for Cardiology(2017)的數據,心血管疾病 (CVD) 每年導致歐洲 390 萬人死亡,歐盟 (EU) 超過 180 萬人死亡。它約佔歐洲所有死亡人數的 45%,佔歐盟死亡人數的 37%。
此外,根據 ESC 2019 年公佈的統計數據,ESC 所有成員國因 CVD 死亡的人數遠遠超過男性和女性因癌症死亡的人數,其中男性 110 萬人,女性 887,688 人受到影響。在高收入國家,癌症死亡人數超過了心血管疾病死亡人數。
此外,根據世界衛生組織(2017)公佈的歐洲數據,歐洲因心血管疾病死亡的人數約為歐洲的46倍。
上述事實表明,迫切需要採取措施來解決全球日益增加的心血管疾病負擔。動脈粥狀硬化和心律不整等適應症會影響患者的生活品質。此外,定期監測心率和活動通常可以降低心血管疾病的嚴重程度。這可以透過部署心電圖監測設備來實現。這些設備不僅使醫療專業人員而且使患者能夠在必要時診斷傳導系統缺陷,不僅有助於改善疾病預後,而且有助於疾病的早期診斷。因此,全球心電圖監測設備市場預計將在預測期內呈現顯著成長。
然而,發展中國家缺乏必要的醫療基礎設施以及嚴格的產品審批監管流程可能會對心電監護設備市場的成長產生一定的限制。
心電監護設備市場細分分析
在心電圖監測設備市場的產品領域中,動態心電圖監測儀領域預計將在預測期內佔據最大的市場份額。動態心電圖監測儀是檢測患者心臟功能異常的最常用設備。它對於診斷和維持正常心臟功能也很有用。這些設備在醫院內普遍使用,並已成為患者心電圖監測的標準和首選方法。
此外,由於它們與心臟連接的時間較長,技術的進步使它們能夠更準確地檢測心跳的不規則性。配備藍牙感測器技術和行動應用程式技術的商業先進動態心電圖監測儀的開發預計將推動全球心電圖市場的普及。
本報告提供了全球心電圖 (ECG) 監測設備市場的研究和分析,包括市場規模和預測、驅動因素和挑戰以及公司和產品概況。
Electrocardiogram (ECG) Monitoring Equipment Market By Product (Resting ECG Systems, Stress ECG Systems, Holter Monitors, Cardiopulmonary Stress Testing System), By Type (Single Lead, 3-6 Lead, 12-Lead), By Modality Type (Portable, Stationary, Wearables), by geography is expected to grow at a steady CAGR forecast till 2030 owing to rising technological advancement and increasing prevalence of cardiovascular diseases
Global Electrocardiogram (ECG) Monitoring Equipment Market was valued at USD 4.44 billion in 2021, growing at a CAGR of 5.74% during the forecast period from 2024 to 2030, to reach USD 6.20 billion by 2030. The demand for Electrocardiogram (ECG) Monitoring Equipment is primarily being boosted by the rising prevalence of cardiovascular diseases, technological advancement in product development, increasing geriatric population, sedentary lifestyle, and increasing awareness regarding cardiovascular diseases.
Electrocardiogram (ECG) Monitoring Equipment Market Dynamics:
Electrocardiogram (ECG) Monitoring Equipment was found to be extremely beneficial as it is the most important test for heart rhythm perception, myocardial ischemia, and infarction diagnosis, defects of the conduction system, preexcitation, long QT syndromes, atrial abnormalities, pericarditis, ventricular hypertrophy, and other disorders.
As per the data provided by the World Health Organization 2021, cardiovascular diseases (CVDs) are the leading cause of death across the globe, wherein this group of disease-account for an estimated 17.9 million lives each year.
CVDs are classified as a group of disorders that specifically affect the heart and blood vessels. Some of the CVDs include coronary heart disease, rheumatic heart disease, cerebrovascular disease, and other conditions.
Furthermore, the same data by the WHO 2021 presented that over four out of five CVD deaths list strokes and heart attacks as the main cause, and one-third of these deaths are said to occur prematurely in people below 70 years of age. Over three-quarters of CVD deaths take place in low- and middle-income countries.
According to the data provided by the European Society for Cardiology (ESC) 2017 data, each year cardiovascular disease (CVD) causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union. They represent about 45% of all deaths in Europe and 37% in the EU.
Additionally, the statistics provided by the ESC for 2019 presented that CVD deaths across ESC member countries far exceeded the cancer deaths for both sexes, affecting 1.1 million males and 887,688 females, although cancer now causes more deaths than CVD in certain high-income countries.
Additionally, as per the data provided by the WHO 2017 data for Europe, deaths, where CVD is listed as a cause, are about 46 times higher in Europe.
The above-mentioned facts state the dire need for measures to address the rising disease burden of CVDs across the globe. Indications such as atherosclerosis, arrhythmias can affect the quality of life of patients. Furthermore, in many cases, the severity of CVDs can be reduced by regular monitoring of cardiac rhythms and activities. This can be achieved by deploying ECG Monitoring Equipment. These devices enable healthcare providers as well as patients to diagnose the defects of the conduction system as per the need, thereby helping in the improvement of disease prognosis as well helping in early disease diagnosis. Therefore, the Global ECG Monitoring Equipment market is expected to witness remarkable growth during the forecast period.
However, non-availability of the required healthcare infrastructure in developing economies, and stringent regulatory process for product approval may prove to be certain restraints to the ECG Monitoring Equipment market growth.
ECG Monitoring Equipment Market Segment Analysis:
ECG Monitoring Equipment by Product (Resting ECG Systems, Stress ECG Systems, Holter Monitors, Cardiopulmonary Stress Testing System), By Type (Single Lead, 3-6 Lead, 12-Lead), By Modality Type (Portable, Stationary, Wearables), By End User (Hospitals, Ambulatory Care, Others), and ECG Monitoring Equipment market by Geography (North America, Europe, Asia-Pacific, and Rest of the World).
ECG Monitoring Equipment market product segment, the Holter monitors segment is expected to amass the largest market share during the forecast period. Holter monitors have been the most commonly used device to detect abnormal heart functioning in patients. They also help in diagnosis and in maintaining the normal functioning of the heart. These devices are generally found in hospitals setups and have been the conventional and most preferred mode of ECG monitoring of patients.
In addition, technological advancements like more accurate detection of any irregularities in the heart's rhythm as it is connected to the heart for a much longer time. The development of commercially advanced Holter monitors, with enabled Bluetooth sensor technology and mobile app technology, is anticipated to drive the popularity of the Global ECG market.
Whereas in the modality type segment, the wearables segment is expected to show faster growth in the forecast period. This can be attributed to the technological advancements, making them accessible to a wider patient population.
Therefore, the constant technological advancements coupled with the extended application of ECG devices present a positive market outlook for the ECG devices among other product types.
North America is expected to dominate the Overall ECG Monitoring Equipment Market:
Among all the regions, North America is expected to account for the largest share in the ECG Monitoring Equipment market. The growing prevalence of cardiovascular diseases, access to better healthcare infrastructure, and growing awareness regarding cardiac diseases coupled with the presence of major ECG Monitoring Equipment market players in the region are predicted to be the major influencing factors in driving the overall growth of the ECG Monitoring Equipment market over the forecast period.
As per the facts provided by the Centers for Disease Prevention and Control (CDC) 2020, heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States where about 655,000 Americans die from heart disease each year.
In addition to the above numbers, the data provided by the American Heart Association mentioned that chronic heart disease remains the leading cause of death in the US, according to 2018 data. The data sheet indicated that in 2018, CHD accounted for approximately 13% of deaths in the US causing 365,744 deaths.
The well-established healthcare infrastructure in the country with supportive reimbursement programs covering the costs for the implantable devices as well as the procedure further encourage people to opt for such devices.
In July 2021, EchoNous, the leader in ultra-portable, AI-guided point-of-care ultrasound (POCUS) tools and software, announced that the company has partnered with Singapore-based Us2.ai, developers of machine learning-driven software that automates the analyses of echocardiographic imagery and measurements.
Considering the presence of a large patient pool in the US coupled with new product launches, the market for ECG Monitoring Equipment looks promising in the United States.
ECG Monitoring Equipment Market Key Players:
Some of the key market players operating in the ECG Monitoring Equipment market include General Electric Company (GE Healthcare), Schiller AG, Koninklijke Philips N.V., Nihon Kohden Corporation, Customed GmbH, CORTEX Biophysik GmbH, Welch Allyn®, Norav Medical, Neurosoft, ACS Diagnostics, Medtronic, Microport Scientific Corporation, LUMED srl Sede legale, iRhythm Technologies, Inc., and others.
Recent Developmental Activities in ECG Monitoring Equipment Market:
In August 2021, Leading smart home medical devices brand Wellue officially announced the launch of its ECG Recorder with AI Analysis.
In July 2021, AliveCor's electrocardiogram (ECG) device, KardiaMobile 6L received the 510(k) clearance from the US Food and Drug Administration (FDA). KardiaMobile 6L is the first-ever handheld ECG device to receive FDA approval for QTc measurement in patients.
In July 2021, Two artificial intelligence (AI) algorithms designed to diagnose people with heart rhythm abnormalities have been approved by the FDA for use with Medtronic's LINQ II cardiac monitor. The AccuRhythm algorithms will be released later this year for use by all implanted LINQ II devices in the US.
Key Takeaways from the ECG Monitoring Equipment Market Report Study
Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the ECG Monitoring Equipment market.
Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
Key companies dominating the Global ECG Monitoring Equipment Market.
Various opportunities are available for the other competitor in the ECG Monitoring Equipment Market space.
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for ECG Monitoring Equipment market growth in the coming future?
Target Audience who can be benefited from this ECG Monitoring Equipment Market Ket Report Study
ECG Monitoring Equipment providers
Research organizations and consulting companies
ECG Monitoring Equipment related organization, association, forum, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders in ECG Monitoring Equipment
Various End-users want to know more about the ECG Monitoring Equipment Market and the latest technological developments in the ECG Monitoring Equipment market.
Frequently Asked Questions for ECG Monitoring Equipment Market:
An electrocardiogram (ECG or EKG) records an electrical pulse from the heart. It is the most important test for heart rhythm perception, myocardial ischemia and infarction diagnosis, defects of the conduction system, preexcitation, long QT syndromes, atrial abnormalities, pericarditis, ventricular hypertrophy, and other disorders.
Global Electrocardiogram (ECG) Monitoring Equipment Market was valued at USD 4.44 billion in 2021, growing at a CAGR of 5.74% during the forecast period from 2024 to 2030, to reach USD 6.20 billion by 2030.
The major drivers driving the demand for ECG Monitoring Equipment are the rising prevalence of cardiovascular diseases, technological advancement in product development, increasing geriatric population, sedentary lifestyle, and increasing awareness regarding cardiovascular diseases.
Some of the key market players operating in the ECG Monitoring Equipment market include General Electric Company (GE Healthcare), Schiller AG, Koninklijke Philips N.V., Nihon Kohden Corporation, Customed GmbH, CORTEX Biophysik GmbH, Welch Allyn®, Norav Medical, Neurosoft, ACS Diagnostics, Medtronic, Microport Scientific Corporation, LUMED srl Sede legale, iRhythm Technologies, Inc., and others.
North America is expected to dominate the overall ECG Monitoring Equipment market during the forecast period, 2024 to 2030. This domination is due to the growing prevalence of cardiovascular diseases, access to better healthcare infrastructure, and growing awareness regarding cardiac diseases coupled with the presence of major market players in the region.